Publication | Closed Access
Comparison of cognitive behavioral and mindfulness meditation interventions on adaptation to rheumatoid arthritis for patients with and without history of recurrent depression.
423
Citations
39
References
2008
Year
PsychotherapyPain TherapyMindfulness InterventionsPain MedicineMental HealthMindfulness InterventionRecurrent DepressionPsychologySocial SciencesMindfulness Meditation InterventionsDepression TreatmentMind-body MedicinePain ManagementCognitive TherapyMindfulness MeditationRheumatoid ArthritisPsychiatryMeditationDepressionCognitive BehavioralMindfulnessPain ResearchMind-body InterventionMedicinePsychopathologyComplementary Medicine
The study tested whether CBT and mindfulness interventions targeting chronic stress, pain, and depression can reduce pain and improve daily life quality in adults with rheumatoid arthritis. Participants (n = 144) were randomized into clusters of 6–10 to receive CBT for pain, mindfulness meditation with emotion regulation, or an education-only control, and data were collected via daily diaries and laboratory measures of pain and IL‑6. CBT produced the largest improvements in pain control and IL‑6 reduction, while both CBT and mindfulness enhanced coping efficacy; however, patients with a history of recurrent depression derived the greatest benefit from mindfulness, showing superior affect and joint tenderness outcomes.
This research examined whether cognitive behavioral therapy and mindfulness interventions that target responses to chronic stress, pain, and depression reduce pain and improve the quality of everyday life for adults with rheumatoid arthritis (RA). The 144 RA participants were clustered into groups of 6-10 participants and randomly assigned to 1 of 3 treatments: cognitive behavioral therapy for pain (P); mindfulness meditation and emotion regulation therapy (M); or education-only group (E), which served as an attention placebo control. The authors took a multimethod approach, employing daily diaries and laboratory assessment of pain and mitogen-stimulated levels of interleukin-6 (IL-6), a proinflammatory cytokine. Participants receiving P showed the greatest Pre to Post improvement in self-reported pain control and reductions in the IL-6; both P and M groups showed more improvement in coping efficacy than did the E group. The relative value of the treatments varied as a function of depression history. RA patients with recurrent depression benefited most from M across several measures, including negative and positive affect and physicians' ratings of joint tenderness, indicating that the emotion regulation aspects of that treatment were most beneficial to those with chronic depressive features.
| Year | Citations | |
|---|---|---|
Page 1
Page 1